NO122835B - - Google Patents

Download PDF

Info

Publication number
NO122835B
NO122835B NO131412A NO13141259A NO122835B NO 122835 B NO122835 B NO 122835B NO 131412 A NO131412 A NO 131412A NO 13141259 A NO13141259 A NO 13141259A NO 122835 B NO122835 B NO 122835B
Authority
NO
Norway
Prior art keywords
floor
horizontal flange
suspension
divider
angle piece
Prior art date
Application number
NO131412A
Other languages
English (en)
Norwegian (no)
Inventor
E Reerink
P Westerhof
H Schoeler
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of NO122835B publication Critical patent/NO122835B/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Conveying And Assembling Of Building Elements In Situ (AREA)
NO131412A 1958-04-12 1959-04-09 NO122835B (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL226774 1958-04-12
NL232312 1958-10-15
NL236884 1959-03-07

Publications (1)

Publication Number Publication Date
NO122835B true NO122835B (hr) 1971-08-23

Family

ID=27351008

Family Applications (1)

Application Number Title Priority Date Filing Date
NO131412A NO122835B (hr) 1958-04-12 1959-04-09

Country Status (13)

Country Link
US (4) US3192201A (hr)
AT (2) AT287213B (hr)
CH (14) CH420130A (hr)
CS (2) CS161826B2 (hr)
DE (1) DE1253707B (hr)
DK (7) DK110201C (hr)
ES (1) ES248593A1 (hr)
FI (2) FI42083B (hr)
FR (1) FR953M (hr)
GB (5) GB929279A (hr)
NO (1) NO122835B (hr)
OA (1) OA02640A (hr)
SE (9) SE342814B (hr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH420130A (de) * 1958-04-12 1966-09-15 Philips Nv Verfahren zur Herstellung neuer Steroide
DE1217374B (de) * 1962-07-10 1966-05-26 Ciba Aktiengesellschaft, Basel (Schweiz) Verfahren zur Herstellung von Zl4,zl5-, oder z)'.4-3-Oxo-10asteroiden
US3235573A (en) * 1962-12-20 1966-02-15 Syntex Corp 19-lower alkylidene and 19-oxo-delta4-androsten-17beta-ol-3-one derivatives
NL123937C (hr) * 1963-11-06
US3463852A (en) * 1966-01-14 1969-08-26 Schering Corp Treating allergies with steroids of the pregnane series
CH481904A (de) * 1966-06-10 1969-11-30 Hoffmann La Roche Verfahren zur Herstellung von neuen 9B, 10a-Steroiden
GB1266361A (hr) * 1969-07-16 1972-03-08
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
CN113880904B (zh) * 2020-07-01 2024-04-12 苏州朗科生物技术股份有限公司 合成地屈孕酮的新方法及化合物
CN114057820B (zh) * 2021-11-15 2023-06-27 湖南科瑞生物制药股份有限公司 一种地屈孕酮的精制方法
CN114957370B (zh) * 2021-12-06 2023-09-19 湖南醇康医药科技有限公司 一种地屈孕酮的制备和纯化方法
CN114957369B (zh) * 2021-12-07 2023-10-31 湖南醇康医药科技有限公司 一种地屈孕酮的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE882399C (de) * 1937-11-28 1953-07-09 Schering Ag Verfahren zur Darstellung von 17-AEthinyl-?-androstenol-17-on-3 und dessen Derivaten
US2752337A (en) * 1951-06-28 1956-06-26 Upjohn Co Steroid enamines
US2739974A (en) * 1953-04-06 1956-03-27 Searle & Co Process of preparing delta4,6-3-ketosteroids
US2871245A (en) * 1956-06-19 1959-01-27 Ciba Pharm Prod Inc New 1-dehydro-testosterones and esters thereof
US2867630A (en) * 1958-06-09 1959-01-06 Upjohn Co 6-fluoro androstenes
CH420130A (de) * 1958-04-12 1966-09-15 Philips Nv Verfahren zur Herstellung neuer Steroide
GB956691A (en) * 1961-10-05 1964-04-29 British Drug Houses Ltd 3-unsubstituted-í¸-androstene compounds

Also Published As

Publication number Publication date
CH415614A (de) 1966-06-30
GB929271A (en) 1963-06-19
GB929277A (en) 1963-06-19
SE341394B (hr) 1971-12-27
CH416612A (de) 1966-07-15
FR953M (hr) 1961-11-27
DK107871C (da) 1967-07-17
OA02640A (fr) 1970-12-15
US3192201A (en) 1965-06-29
FI42083B (hr) 1970-02-02
AT281307B (de) 1970-05-25
US3445489A (en) 1969-05-20
DK124079B (da) 1972-09-11
CH432505A (de) 1967-03-31
CH428720A (de) 1967-01-31
GB929276A (en) 1963-06-19
CH420130A (de) 1966-09-15
SE341401B (hr) 1971-12-27
SE341399B (hr) 1971-12-27
CH455765A (de) 1968-05-15
SE341848B (hr) 1972-01-17
CH415613A (de) 1966-06-30
DK115038B (da) 1969-09-01
FI42212B (hr) 1970-03-02
SE341397B (hr) 1971-12-27
CH415615A (de) 1966-06-30
DK118503B (da) 1970-08-31
CH464183A (de) 1968-10-31
CH430710A (de) 1967-02-28
DK110201C (da) 1970-11-30
GB929279A (en) 1963-06-19
US3362968A (en) 1968-01-09
SE341400B (hr) 1971-12-27
CH420131A (de) 1966-09-15
CH432506A (de) 1967-03-31
CH441299A (de) 1967-08-15
US3373172A (en) 1968-03-12
DE1253707B (de) 1967-11-09
GB929278A (en) 1963-06-19
SE342814B (hr) 1972-02-21
DK103510C (da) 1966-01-17
CH434244A (de) 1967-04-30
ES248593A1 (es) 1959-11-16
SE341398B (hr) 1971-12-27
DK108571C (da) 1968-01-08
CS149567B2 (hr) 1973-07-25
SE342445B (hr) 1972-02-07
CS161826B2 (hr) 1975-06-10
AT287213B (de) 1971-01-11

Similar Documents

Publication Publication Date Title
NO122835B (hr)
US2963126A (en) Wall structure
US2879660A (en) Adjustable lining support
NO149783B (no) Anordning ved skillevegg som bestaar av forskyvbare paneler
US2142523A (en) Building construction
NO132809B (hr)
NO177830B (no) Feste- og justeringsanordning for flate byggeelementer av en hengefasade av en bygning, hvor fasaden oppviser vertikale stolper
NO852928L (no) Plateformet byggeelement og byggekonstruksjon med slike byggeelementer.
US2994415A (en) Connecting means for structural elements
ES231164A1 (es) Perfeccionamientos en tejadillos y construcciones similares
US2687102A (en) Truss support
US3233374A (en) Building and method of constructing same
NO801984L (no) Anordning ved forskalingssystem.
IE33894L (en) Structure made of prefabricated elements
NO782420L (no) Plantebord for drivhus.
US2260353A (en) Prefabricated house construction
FR2303908A2 (fr) Cloison pour batiments
GB1443278A (en) Walter support for wall form systems
GB1128877A (en) Furnace wall structure
US2405584A (en) System of building construction
US1871976A (en) Sheet metal form and sheet metal lath
US4287695A (en) Prefabricated building
US2724875A (en) Patio cover
US2136987A (en) Greenhouse and other portable buildings
NO852867L (no) Modulbyggesystem for skip e.l. konstruksjoner.